Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HSCT-México Program is a specialized medical center located in Puebla and Monterrey, Mexico, that focuses on providing autologous hematopoietic stem cell transplantation (aHSCT) for patients with autoimmune diseases. The program is operated by Clínica Ruiz, a premier hematology institution founded in 1949 with a long history of clinical excellence and research. It is particularly well-known for treating Multiple Sclerosis (MS) using a specific non-myeloablative conditioning regimen designed to minimize toxicity while effectively resetting the patient's immune system. As one of the highest-volume HSCT centers in the world, the program has treated thousands of international patients and contributes significantly to peer-reviewed medical literature regarding transplant outcomes. The facility offers a comprehensive treatment package that includes stem cell collection, conditioning, transplantation, and post-transplant care in an outpatient-oriented setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HSCT-México Program.